Stryker (SYK) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8636671013

Orthopedic, Spinal, Surgical, Neurosurgical, Medical, Implant, Equipment

Stryker Corporation is a leading medical technology company that operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.

The Orthopaedics and Spine segment focuses on providing innovative implants and solutions for various orthopedic and spine-related procedures. This includes implants for total joint replacements, such as hip, knee, and shoulder replacements, as well as trauma and extremities surgeries. Additionally, this segment offers a range of spinal implant products, including cervical and thoracolumbar systems, used in spinal injury, complex spine, and degenerative therapies.

The MedSurg and Neurotechnology segment is a diverse portfolio of medical devices and solutions. This includes surgical equipment, surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, and intensive care disposable products. This segment also offers neurosurgical, neurovascular, and craniomaxillofacial implant products, which are used in various medical specialties. These products include minimally invasive endovascular procedures, brain and open skull-based surgical procedures, orthobiologic and biosurgery products, and craniomaxillofacial implant products.

Stryker Corporation sells its products to doctors, hospitals, and other healthcare facilities through a global network of company-owned subsidiaries and branches, as well as third-party dealers and distributors. With operations in approximately 75 countries, Stryker is a truly global company.

Founded in 1941, Stryker Corporation is headquartered in Portage, Michigan, and has a strong commitment to innovation, quality, and customer satisfaction. The company's website,, provides more information on its products, services, and mission to improve healthcare outcomes.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Stryker (SYK) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Stryker (SYK) - Stock Price & Dividends

SYK Stock Overview

Market Cap in USD 130,673m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1988-02-01

SYK Stock Ratings

Growth 5y 60.5
Fundamental 64.7
Dividend 6.93
Rel. Performance vs Sector 0.38
Analysts 4.03/5
Fair Price Momentum 331.44 USD
Fair Price DCF 205.63 USD

SYK Dividends

Yield 12m 0.90%
Yield on Cost 5y 1.60%
Dividends CAGR 5y 7.39%
Payout Consistency 93.4%

SYK Growth Ratios

Growth 12m 16.22%
Growth Correlation 12m 51%
Growth Correlation 3m -10%
CAGR 5y 12.08%
CAGR/Mean DD 5y 1.50
Sharpe Ratio 12m 0.54
Alpha vs SP500 12m -15.23
Beta vs SP500 5y weekly 1.18
ValueRay RSI 35.98
Volatility GJR Garch 1y 17.49%
Price / SMA 50 1.74%
Price / SMA 200 9.05%
Current Volume 1838k
Average Volume 20d 1258.4k

External Links for SYK Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of SYK stocks?
As of June 22, 2024, the stock is trading at USD 342.64 with a total of 1,837,959 shares traded.
Over the past week, the price has changed by -0.68%, over one month by +3.67%, over three months by -2.85% and over the past year by +16.34%.
What are the forecast for SYK stock price target?
According to ValueRays Forecast Model, SYK Stryker will be worth about 369.5 in June 2025. The stock is currently trading at 342.64. This means that the stock has a potential upside of +7.82%.
Issuer Forecast Upside
Wallstreet Target Price 379 10.6
Analysts Target Price 317.1 -7.46
ValueRay Target Price 369.5 7.82

Stryker Corporation: From Humble Beginnings to Global Leader

Stryker Corporation, globally recognized by its ticker symbol NYSE:SYK, stands out as one of the top-tier medical technology companies worldwide. The company's journey, its diverse product offerings, and its remarkable standing in the current market showcase its dedication to improving healthcare through innovative solutions.

History: The Foundation of Stryker

Stryker's story begins in 1941, with its founder, Dr. Homer Stryker, an orthopedic surgeon frustrated by the limitations of medical equipment available at the time. His inventions, aimed at addressing these challenges, laid the foundation for Stryker Corporation. The company's early focus was on creating products that enhanced patient and hospital outcomes, a core principle that continues to drive its operations.

Core Business: Advancing Medical Technology

At its heart, Stryker specializes in a wide array of medical technologies, including orthopedics, medical and surgical equipment, and neurotechnology and spine products. Its portfolio spans from joint replacement solutions and surgical equipment to neurovascular therapies and advanced wound care. This diverse range of products underscores Stryker's commitment to innovation and its role in supporting healthcare professionals and patients alike.

Side Business: Diversification and Growth

Beyond its primary offerings, Stryker has also strategically expanded into related areas. These include emergency medical services, digital solutions for surgery, and hospital information systems. This diversification not only broadens Stryker's impact across the healthcare sector but also enhances its resilience and adaptability in a constantly evolving market.

Current Market Status: A Leader Among Giants

Today, Stryker's standing in the global medical technology market is both prominent and influential. With a strong growth trajectory, the company continues to deliver on its commitment to innovation, garnering global recognition and a robust financial performance. Stryker's strategic acquisitions and a focus on research and development have further solidified its market position, making it a preferred partner for healthcare facilities and professionals worldwide.